Publication:
Mutations in PIK3CA Sensitize Breast Cancer Cells to Physiologic Levels of Aspirin

Simple item page
dc.contributor.authorsDirican, Ebubekir
dc.date.accessioned2022-03-25T19:39:22Z
dc.date.accessioned2026-01-11T06:01:27Z
dc.date.available2022-03-25T19:39:22Z
dc.date.issued2016
dc.identifier.issn2476-762X
dc.identifier.pubmedPMID: 27268661
dc.identifier.urihttps://hdl.handle.net/11424/254821
dc.language.isoeng
dc.relation.ispartofAsian Pacific journal of cancer prevention: APJCP
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectFemale
dc.subjectHumans
dc.subjectPrognosis
dc.subjectMutation
dc.subjectAnti-Inflammatory Agents, Non-Steroidal
dc.subjectAspirin
dc.subjectBreast Neoplasms
dc.subjectPhosphatidylinositol 3-Kinases
dc.subjectClass I Phosphatidylinositol 3-Kinases
dc.titleMutations in PIK3CA Sensitize Breast Cancer Cells to Physiologic Levels of Aspirin
dc.typearticle
dspace.entity.typePublication
oaire.citation.startPage2731
oaire.citation.titleAsian Pacific journal of cancer prevention: APJCP
oaire.citation.volume5

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
file.pdf
Size:
255.1 KB
Format:
Adobe Portable Document Format
Download

Collections

Araştırma Çıktıları